1. Home
  2. FNLC vs MOBI Comparison

FNLC vs MOBI Comparison

Compare FNLC & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Bancorp Inc  (ME)

FNLC

First Bancorp Inc (ME)

HOLD

Current Price

$34.60

Market Cap

384.5M

Sector

Finance

ML Signal

HOLD

MOBI

Mobia Medical Inc. Common Stock

N/A

Current Price

$14.42

Market Cap

366.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNLC
MOBI
Founded
1864
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
384.5M
366.1M
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
FNLC
MOBI
Price
$34.60
$14.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.7K
94.5K
Earning Date
04-22-2026
N/A
Dividend Yield
5.19%
N/A
EPS Growth
26.34
N/A
EPS
0.80
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.13
$12.66
52 Week High
$34.50
$14.40

Technical Indicators

Market Signals
Indicator
FNLC
MOBI
Relative Strength Index (RSI) 80.68 N/A
Support Level $28.08 N/A
Resistance Level N/A N/A
Average True Range (ATR) 1.30 0.00
MACD 0.53 0.00
Stochastic Oscillator 99.01 0.00

Price Performance

Historical Comparison
FNLC
MOBI

About FNLC First Bancorp Inc (ME)

First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services, including deposit accounts and consumer, commercial, and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.

About MOBI Mobia Medical Inc. Common Stock

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.

Share on Social Networks: